Back
37
Day Range
$104.10
$107.07
52-Week Range
$104.10
$139.06
Volume
5,891,472
50D / 200D Avg
$113.11
/
$125.68
Prev Close
$105.46
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 27.9 | 0.4 |
| P/B | 3.5 | 2.9 |
| ROE % | 13.1 | 3.7 |
| Net Margin % | 14.7 | 3.8 |
| Rev Growth 5Y % | 0.7 | 10.0 |
| D/E | 0.3 | 0.2 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 |
Shroff Eric
Senior Vice President
|
sell | 709 | $115.58 | $81,946 |
| Mar 2, 2026 |
Cushman Elizabeth C.
EVP, GC AND SECRETARY
|
sell | 263 | $115.58 | $30,398 |
| Mar 2, 2026 |
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
|
sell | 1,144 | $115.58 | $132,224 |
| Feb 27, 2026 |
Shroff Eric
Senior Vice President
|
other | 1,384 | $116.26 | $160,904 |
| Feb 27, 2026 |
Boudreau Philip P
EVP AND CFO
|
other | 7,441 | $116.26 | $865,091 |
| Feb 27, 2026 |
Ford Robert B
CHAIRMAN AND CEO
|
other | 30,308 | $116.26 | $3,523,608 |
| Feb 27, 2026 |
Cushman Elizabeth C.
EVP, GC AND SECRETARY
|
other | 1,421 | $116.26 | $165,205 |
| Feb 27, 2026 |
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
|
other | 4,040 | $116.26 | $469,690 |
| Feb 24, 2026 |
Ford Robert B
CHAIRMAN AND CEO
|
grant | 427,530 | — | — |
| Dec 31, 2025 |
Stratton John G
|
grant | 313 | $125.29 | $39,216 |
| Dec 31, 2025 |
Roman Michael F
|
grant | 301 | $125.29 | $37,712 |
| Dec 11, 2025 |
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
|
other | 1,536 | $123.28 | $189,358 |
| Sep 30, 2025 |
Stratton John G
|
grant | 293 | $133.94 | $39,244 |
| Jun 30, 2025 |
Stratton John G
|
grant | 282 | $136.01 | $38,355 |
| Jun 30, 2025 |
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
|
other | 269 | $134.38 | $36,148 |
| Jun 30, 2025 |
Gonzalez Patricia Paola
|
grant | 242 | $136.01 | $32,914 |
| Apr 30, 2025 |
Blount Sally E.
|
sell | 2,600 | $129.66 | $337,116 |
| Apr 25, 2025 |
Roman Michael F
|
grant | 1,635 | — | — |
| Apr 25, 2025 |
McDew Darren W
|
grant | 1,635 | — | — |
| Mar 31, 2025 |
Gonzalez Patricia Paola
|
grant | 248 | $132.65 | $32,897 |
Key Takeaways
Revenue grew 0.72% annually over 5 years — modest growth
Earnings declined -51.32% over the past year
ROE of 13.07% — decent returns on equity
Debt/Equity of 0.29 — conservative balance sheet
Generating 7.40B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.95%
Growth
Revenue Growth (5Y)
0.72%
Revenue (1Y)5.67%
Earnings (1Y)-51.32%
FCF Growth (3Y)20.90%
Quality
Return on Equity
13.07%
ROIC8.98%
Net Margin14.72%
Op. Margin18.16%
Safety
Debt / Equity
0.29
Current Ratio1.58
Interest Coverage23.60
Valuation
P/E Ratio
27.93
P/B Ratio3.50
EV/EBITDA23.45
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.67% | Revenue Growth (3Y) | 5.13% |
| Earnings Growth (1Y) | -51.32% | Earnings Growth (3Y) | 6.77% |
| Revenue Growth (5Y) | 0.72% | Earnings Growth (5Y) | -1.99% |
| Profitability | |||
| Revenue (TTM) | 44.33B | Net Income (TTM) | 6.52B |
| ROE | 13.07% | ROA | 7.52% |
| Gross Margin | 55.51% | Operating Margin | 18.16% |
| Net Margin | 14.72% | Free Cash Flow (TTM) | 7.40B |
| ROIC | 8.98% | FCF Growth (3Y) | 20.90% |
| Safety | |||
| Debt / Equity | 0.29 | Current Ratio | 1.58 |
| Interest Coverage | 23.60 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 27.93 | P/B Ratio | 3.50 |
| P/S Ratio | 4.11 | PEG Ratio | -0.65 |
| EV/EBITDA | 23.45 | Dividend Yield | 0.02% |
| Market Cap | 182.20B | Enterprise Value | 188.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44.33B | 41.95B | 40.11B | 43.65B | 43.08B |
| Net Income | 6.52B | 13.40B | 5.72B | 6.93B | 7.07B |
| EPS (Diluted) | 3.72 | 7.64 | 3.27 | 3.91 | 3.94 |
| Gross Profit | 24.61B | 21.33B | 20.04B | 22.32B | 23.21B |
| Operating Income | 8.05B | 6.83B | 6.44B | 8.36B | 9.20B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 86.71B | 81.41B | 73.21B | 74.44B | 75.20B |
| Total Liabilities | 33.94B | 33.51B | 34.39B | 37.53B | 39.17B |
| Shareholders' Equity | 52.13B | 47.66B | 38.60B | 36.69B | 35.80B |
| Total Debt | 15.07B | 15.28B | 15.87B | 17.95B | 19.25B |
| Cash & Equivalents | 8.52B | 7.62B | 6.90B | 9.88B | 9.80B |
| Current Assets | 26.00B | 23.66B | 22.67B | 25.22B | 24.24B |
| Current Liabilities | 16.50B | 14.16B | 13.84B | 15.49B | 13.11B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#685 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026